Search Medical Condition
Please enter condition
Please choose location from dropdown

Chonju, Korea, Republic of Clinical Trials

A listing of Chonju, Korea, Republic of clinical trials actively recruiting patients volunteers.

RESULTS

Found (71) clinical trials

Efficacy and Safety of Hydrolysed Red Ginseng Extract on Dry Eye

This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. 46 subjects were randomly divided into Hydrolysed Red Ginseng extract 10ml or placebo group. The investigators measured Ocular Surface Disease Index, tear break-up time, Visual analog scale, Schirmer's test, meibomian gland test and Fluorescein staining.

Phase N/A

0.0 miles

Learn More »

Efficacy and Safety Morus Alba L. Extract on Improvement of Blood Flow

This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. Hundred subjects were randomly divided into Morus alba L. extract or a placebo group. Blood was collected and changes in blood circulation related indicators were observed.

Phase N/A

0.0 miles

Learn More »

Efficacy and Safety of Soybean Germ Extract on Decrease of Body Fat

This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. 80 subjects were randomly divided into Soybean germ extract 1,600 mg or placebo group. The investigators measured Body Fat Mass, Percent Body Fat, Fat Free Mass, weight, and body mass index, etc.

Phase N/A

0.0 miles

Learn More »

Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Hyperglycemia

This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. Twenty subjects were randomly divided into Hydrolysed Red Ginseng extract or a placebo group. Fasting and postprandial glucose profiles during oral glucose tolerance test (OGTT) were assessed before and after the intervention.

Phase N/A

0.0 miles

Learn More »

Novel Biomarkers in Chronic Airway Diseases

The purpose of this study is: - To define The differences of bio-chemical phenotypes in chronic airway inflammatory diseases. - To identify novel biomarkers in chronic airway inflammatory diseases as a screening, diagnostic, or monitoring marker.

Phase N/A

1.26 miles

Learn More »

Observational Study of Pertuzumab Safety in Participants With Breast Cancer

This Phase IV, prospective, multicenter, non-interventional study (regulatory post-marketing surveillance) will evaluate the safety of pertuzumab in approximately 3000 participants with metastatic or locally unresectable recurrent breast cancer who have never received chemotherapy or anti-human epidermal growth factor receptor 2 (HER2) therapy for their metastatic disease with HER2 positivity in ...

Phase N/A

7.38 miles

Learn More »

An Observational Study of Herceptin SC Safety in Breast Cancer

This is a phase IV, prospective, multicenter, observational study (regulatory post-marketing surveillance) in approximately 600 patients who are to receive Herceptin SC (trastuzumab, subcutaneous administration) per approved local labeling. Patients will be under observation according to standard of care in Korea.

Phase N/A

7.38 miles

Learn More »

Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS

A multicenter, randomized, comparative, open-label, phase 3 study Primary Objective: To assess the vaccine response rates after the three-dose primary vaccination Secondary Objectives: To measure the antibody titer after the three-dose primary vaccination and to assess the safety of the investigational products

Phase

7.38 miles

Learn More »

Study of Adjuvant ONO-4538 With Resected Gastric Cancer

The purpose of study is to evaluate the efficacy and safety of postoperative adjuvant chemotherapy with Nivolumab in combination with tegafur-gimeracil-oteracil potassium (S-1 therapy) or capecitabine + oxaliplatin (CapeOX therapy), in comparison with placebo in combination with S-1 therapy or CapeOX therapy, in pStage III gastric cancer (including esophagogastric junction ...

Phase

7.38 miles

Learn More »

A Study of Atezolizumab (Tecentriq ) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)

This Phase 4, prospective, multicenter, non-interventional, regulatory post-marketing surveillance study will collect information on the the safety and effectiveness of atezolizumab under the clinical practice, and update the drug label approved by the MFDS in Korea.

Phase N/A

7.38 miles

Learn More »